We firstly confirmed the ADAM10 KO in tumours by immunoprecipitation from tumour extracts, using the human ADAM10-specific antibody 4A11 [25] to differentiate ADAM10 in human tumour cells versus mouse cells of the host microenvironment. This evidence concerns the gene ADAM10 and neoplasm.